These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


231 related items for PubMed ID: 15104609

  • 41. Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit.
    Forfia PR, Watkins SP, Rame JE, Stewart KJ, Shapiro EP.
    J Am Coll Cardiol; 2005 May 17; 45(10):1667-71. PubMed ID: 15893185
    [Abstract] [Full Text] [Related]

  • 42. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J, McKelvie RS, Persson H, Tait P, Carlsson J, Swedberg K, Ostergren J, Lonn E.
    Am J Cardiol; 2008 Sep 15; 102(6):733-7. PubMed ID: 18773998
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Amino-terminal fragment of C-type natriuretic peptide precursor and C-type natriuretic peptide do not correlate in patients with Chagas disease: role for neutral endopeptidase.
    Wang Y, Moreira Mda C, Heringer-Walther S, Schultheiss HP, Siems WE, Wessel N, Walther T.
    J Cardiovasc Pharmacol; 2010 Jan 15; 55(1):62-6. PubMed ID: 20090473
    [Abstract] [Full Text] [Related]

  • 46. Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population.
    Lam CS, Burnett JC, Costello-Boerrigter L, Rodeheffer RJ, Redfield MM.
    J Am Coll Cardiol; 2007 Mar 20; 49(11):1193-202. PubMed ID: 17367664
    [Abstract] [Full Text] [Related]

  • 47. Physiological, pathological, pharmacological, biochemical and hematological factors affecting BNP and NT-proBNP.
    Balion CM, Santaguida P, McKelvie R, Hill SA, McQueen MJ, Worster A, Raina PS.
    Clin Biochem; 2008 Mar 20; 41(4-5):231-9. PubMed ID: 17967418
    [Abstract] [Full Text] [Related]

  • 48. Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study.
    Das SR, Drazner MH, Dries DL, Vega GL, Stanek HG, Abdullah SM, Canham RM, Chung AK, Leonard D, Wians FH, de Lemos JA.
    Circulation; 2005 Oct 04; 112(14):2163-8. PubMed ID: 16203929
    [Abstract] [Full Text] [Related]

  • 49. BNP and N-terminal proBNP are both extracted in the normal kidney.
    Goetze JP, Jensen G, Møller S, Bendtsen F, Rehfeld JF, Henriksen JH.
    Eur J Clin Invest; 2006 Jan 04; 36(1):8-15. PubMed ID: 16403004
    [Abstract] [Full Text] [Related]

  • 50. Comparative value of BNP and NT-proBNP in diagnosis of heart failure.
    Fonseca C, Sarmento PM, Minez A, Gonçalves E, Covas R, Dias AR, Pina MJ, Ceia F.
    Rev Port Cardiol; 2004 Jan 04; 23(7-8):979-91. PubMed ID: 15478324
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Neutral endopeptidase 24.11 in neutrophils modulates protective effects of natriuretic peptides against neutrophils-induced endothelial cytotoxity.
    Matsumura T, Kugiyama K, Sugiyama S, Ohgushi M, Amanaka K, Suzuki M, Yasue H.
    J Clin Invest; 1996 May 15; 97(10):2192-203. PubMed ID: 8636398
    [Abstract] [Full Text] [Related]

  • 54. Brain and other natriuretic peptides: molecular aspects.
    Vanderheyden M, Bartunek J, Goethals M.
    Eur J Heart Fail; 2004 Mar 15; 6(3):261-8. PubMed ID: 14987574
    [Abstract] [Full Text] [Related]

  • 55. Potentiation of brain natriuretic peptides by SQ 28,603, an inhibitor of neutral endopeptidase 3.4.24.11, in monkeys and rats.
    Seymour AA, Asaad MM, Abboa-Offei BE, Rovnyak PL, Fennell S, Rogers WL.
    J Pharmacol Exp Ther; 1992 Jul 15; 262(1):60-70. PubMed ID: 1385630
    [Abstract] [Full Text] [Related]

  • 56. Apparent B-type natriuretic peptide selectivity in the kidney due to differential processing.
    Kishimoto I, Hamra FK, Garbers DL.
    Can J Physiol Pharmacol; 2001 Aug 15; 79(8):715-22. PubMed ID: 11558680
    [Abstract] [Full Text] [Related]

  • 57. Reference values for N-terminal pro-B-type natriuretic peptide in fetal circulation between 20 and 34 weeks of gestation.
    Merz WM, Kübler K, Albers E, Stoffel-Wagner B, Gembruch U.
    Clin Biochem; 2010 Mar 15; 43(4-5):519-21. PubMed ID: 19968983
    [Abstract] [Full Text] [Related]

  • 58. Effect of estimated glomerular filtration rate on plasma concentrations of B-type natriuretic peptides measured with multiple immunoassays in elderly individuals.
    Schou M, Alehagen U, Goetze JP, Gustafsson F, Dahlstrom U.
    Heart; 2009 Sep 15; 95(18):1514-9. PubMed ID: 19570761
    [Abstract] [Full Text] [Related]

  • 59. Genome-Wide Association Study Implicates Atrial Natriuretic Peptide Rather Than B-Type Natriuretic Peptide in the Regulation of Blood Pressure in the General Population.
    Salo PP, Havulinna AS, Tukiainen T, Raitakari O, Lehtimäki T, Kähönen M, Kettunen J, Männikkö M, Eriksson JG, Jula A, Blankenberg S, Zeller T, Salomaa V, Kristiansson K, Perola M.
    Circ Cardiovasc Genet; 2017 Dec 15; 10(6):e001713. PubMed ID: 29237677
    [Abstract] [Full Text] [Related]

  • 60. Single assay for amino-terminal fragments of cardiac A- and B-type natriuretic peptides.
    Ala-Kopsala M, Ruskoaho H, Leppäluoto J, Seres L, Skoumal R, Toth M, Horkay F, Vuolteenaho O.
    Clin Chem; 2005 Apr 15; 51(4):708-18. PubMed ID: 15718490
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.